Improving responses to immunotherapy in glioblastoma multiforme

被引:0
作者
McArdle, Stephanie E. B. [1 ,2 ]
Nagarajan, Divya [3 ]
Barish, Michael E. [4 ]
机构
[1] Nottingham Trent Univ, John van Geest Canc Res Ctr, Nottingham, England
[2] Nottingham Trent Univ, Sch Sci & Technol, Dept Biosci, Nottingham, England
[3] Pencil Biosci Ltd, Macclesfield, England
[4] Beckman Res Inst, Dept Stem Cell Biol & Regenerat Med, City Hope, Duarte, CA USA
关键词
glioblastoma multiforme (GBM); immunotherapy; responses; improve; future;
D O I
10.3389/fimmu.2024.1407930
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
[31]   Current Immunotherapies for Glioblastoma Multiforme [J].
Huang, Boyuan ;
Li, Xuesong ;
Li, Yuntao ;
Zhang, Jin ;
Zong, Zhitao ;
Zhang, Hongbo .
FRONTIERS IN IMMUNOLOGY, 2021, 11
[32]   Reactive Astrocytes in Glioblastoma Multiforme [J].
Xiudong Guan ;
Md Nabiul Hasan ;
Shelly Maniar ;
Wang Jia ;
Dandan Sun .
Molecular Neurobiology, 2018, 55 :6927-6938
[33]   Targeting Cancer Stem Cells for Treatment of Glioblastoma Multiforme [J].
Cho, Der-Yang ;
Lin, Shinn-Zong ;
Yang, Wen-Kuang ;
Lee, Han-Chung ;
Hsu, Den-Mei ;
Lin, Hung-Lin ;
Chen, Chun-Chung ;
Liu, Chun-Lin ;
Lee, Wen-Yuan ;
Ho, Li-Hui .
CELL TRANSPLANTATION, 2013, 22 (04) :731-739
[34]   Therapeutic cell-based vaccines for glioblastoma multiforme [J].
Pour, Mehrshad Ebrahim ;
Moghadam, Samin Ghorbani ;
Shirkhani, Parian ;
Sahebkar, Amirhossein ;
Mosaffa, Fatemeh .
MEDICAL ONCOLOGY, 2023, 40 (12)
[35]   Immunotherapy in Glioblastoma [J].
Wilcox, Jessica A. ;
Ramakrishna, Rohan ;
Magge, Rajiv .
WORLD NEUROSURGERY, 2018, 116 :518-528
[36]   Bioengineering human heavy-chain nanoferritin for glioblastoma multiforme-specific delivery and efficient immunotherapy [J].
Yan, Han ;
Cheng, Wenting ;
Qin, Siyuan ;
Zuo, Jing ;
Li, Lei ;
Zhang, Jing ;
Chang, Qinxia ;
Yan, Yonghao ;
Wang, Shiqi ;
Huang, Canhua ;
Zhang, Haiyuan .
CHEMICAL ENGINEERING JOURNAL, 2024, 501
[37]   LOCAL IMMUNOTHERAPY OF RECURRENT GLIOBLASTOMA-MULTIFORME BY INTRACEREBRAL PERFUSION OF INTERLEUKIN-2 AND LAK CELLS [J].
BLANCHER, A ;
ROUBINET, F ;
GRANCHER, AS ;
TREMOULET, M ;
BONATE, A ;
DELISLE, MB ;
CALOT, JP ;
POURREAU, C ;
FRANKS, C ;
DUCOS, J ;
RASCOL, A ;
CLANET, M .
EUROPEAN CYTOKINE NETWORK, 1993, 4 (05) :331-341
[38]   The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme [J].
Daei Sorkhabi, Amin ;
Sarkesh, Aila ;
Saeedi, Hossein ;
Marofi, Faroogh ;
Ghaebi, Mahnaz ;
Silvestris, Nicola ;
Baradaran, Behzad ;
Brunetti, Oronzo .
FRONTIERS IN ONCOLOGY, 2022, 12
[39]   Identification of HLA a*0201 glioblastoma multiforme cell lines for immunotherapy by PCR-SSP and DNA sequencing [J].
Wu, AH ;
Hall, WA ;
Low, WC .
JOURNAL OF NEURO-ONCOLOGY, 2004, 66 (1-2) :1-8
[40]   Detection of immune responses after immunotherapy in glioblastoma using PET and MRI [J].
Antonios, Joseph P. ;
Soto, Horacio ;
Everson, Richard G. ;
Moughon, Diana L. ;
Wang, Anthony C. ;
Orpilla, Joey ;
Radu, Caius ;
Ellingson, Benjamin M. ;
Lee, Jason T. ;
Cloughesy, Timothy ;
Phelps, Michael E. ;
Czernin, Johannes ;
Liau, Linda M. ;
Prins, Robert M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (38) :10220-10225